The Society of Gynecologic Oncology of Canada (GOC) invites researchers from around the world to submit abstracts for presentation at the 40+ Annual General Meeting (AGM) which will be held at the Fairmont Chateau Laurier in Ottawa, Ontario from June 8th to June 10th, 2023. 

The meeting will feature a wide range of exciting talks, discussions, and networking opportunities with experts, researchers, trainees and leaders in the field of gynecologic oncology. Investigators at all career stages are encouraged to submit as many abstracts as they would like.

Your best-ranking abstract will be included in the competition for oral presentation, all other abstracts will be presented as posters and/or video presentations.

• The deadline for abstract submissions is Friday, March 17, 2023, at 11:59pm PST. No extensions will be accepted.
• All abstracts must be received through the online abstract submission form​ before the deadline. Incomplete or late submissions will not be accepted.
• A clear and concise abstract should not include graphs, tables and references.
• Title: formatted in sentence case, not Title Case of UPPERCASE. The title should be brief and clearly indicate the nature of the abstract.
• A list of all authors including their full names, designations and institutional affiliations.
• Abstract text should be a maximum of 300 words and include:
• Objective(s): state the study purpose in a concise manner.
• Study methods: indicate the location, number and type of human subjects, non-human species or material being studied, the principal test(s) performed, and the type(s) of statistical analysis if applicable.
• Results: confirm or refute the hypothesis, supported by statistics if appropriate.
• Conclusion: State the summary of the results and the impact the study has in the related field of research.
• Professional Status: MD (attending staff), Fellow-in-training including those doing their research year, Resident, Medical Student, Scientist, Ph.D. or MSc student, Registered Nurse, or Other. Note: it is key to the program that you select the correct professional status.
• You will be asked to complete a disclosure of any conflict of interest if your abstract is selected for presentation. 
• The abstract text will be published exactly as submitted therefore please proofread before submitting to ensure it is published without typos!

• Abstract type: Completed work, *Work in Progress, Video. *Work in Progress provides a venue to present new ideas and preliminary studies and research in progress. Work in Progress submissions are invited in the form of ePosters only.
• Abstract Categories: Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Vulvar Cancer, BRCA, Other.
• Abstract Sub-Categories: Clinical, Health Services Research/Health Policy, Basic Science or Translational, Innovations in Care/Education.

• GOC continues to encourage original video submissions for peer-review. Your surgical video must pertain to a topic related to gynecologic oncology.
• Submit a written summary describing the content of the video that is no more than 300 words by the abstract submission deadline. The video submission will be required later if the written submission is accepted.
• Hospital protocol for video recording with patient permission or equivalent must have been followed.
• All video presentations must be edited and narrated on the audio track in English.
• No music is allowed in video recordings.
• Total video length should not exceed 5 minutes including title, introduction and spoken narrative.
• The video file must be in MP4 format. The video cannot be promotional or commercial in nature.

Submissions will be evaluated using the following criteria (each on a five-point scale):

• Relevance to gynecologic oncology;
• Clarity of the research question and appropriateness of the methods;
• Trustworthiness of the results/findings;
• Potential impact of the findings or conclusions;
• Overall interest to healthcare provides who treat or have an interest in gynecologic oncology.

Features that increase the likelihood of results being trustworthy:

• Cohort/observational studies: inclusion criteria are clear; sample size is sufficient; validated and reliable measures are used; response rate is greater than 80 per cent; follow-up rate is greater than 80 per cent (if longitudinal); statistical analysis is appropriate; conclusions are justified by the results/findings;
• Trials: inclusion criteria are clear; allocation is randomized; randomization is concealed; blindness is considered; sample size is sufficient; valid and reliable measures are used; follow-up rate is acceptable; statistical analysis is appropriate; conclusions are justified by the results/findings;
• Qualitative studies: methodology is stated (e.g., grounded theory, phenomenology); sampling is justified (e.g., purposive, theoretical, snowball); data are collected; type of analysis is described (e.g., iterative, thematic, constant comparison); conclusions are justified by the findings.

• The primary presenter will have to register for the meeting.
• The event is in-person only and those invited to present will be able to present from the AGM event in Ottawa in June 2023.
• Information will be sent to the original submitter only; therefore, we ask that this individual share all correspondence/instructions with co-presenters.
• It is important to state all conflicts of interest upfront upon submission. If any affiliations exist, with you or any of your co-presenters, please state how these will be mitigated with your submission. The primary presenter of each session is responsible for ensuring all co-presenters complete and submit a Conflict-of-Interest form.
• If your abstract is accepted for the program, it is extremely important that you honour the commitment to present. You will have to confirm your attendance if you receive a selection email. It is also greatly appreciated if you submit a copy of your poster/slides/recording/etc. in advance of your presentation. . All presentations are retained and used exclusively by GOC for educational and promotional purposes as needed.

• All abstracts submitted for consideration for oral, poster and video presentations will be peer- reviewed. Oral, Video and Poster abstracts will be presented during the Annual General Meeting. 
• Top-scoring abstract submissions will be invited to present as oral presentations. Each presenter may only present one oral presentation during the meeting.
• Video submissions will be presented in a designated session.
• All submissions are eligible for peoples' choice awards in their respective categories.
• Once accepted, the abstract final presentation files will be requested, the deadline for the submission will be communicated to you. Any presentation that is not submitted by this deadline will be withdrawn from the AGM meeting.
• For any assistance or questions, please contact us via email at enquiry@gyneoncology.ca.